Bodybuilders and others who want to boost muscle growth can use Dindolyl Methane (or DIM). However there have been some recent links to health hazards that DIM can cause. For instance, DIM can cause serious liver damage when consumed in excess. Another risk is kidney damage, which could lead to kidney failure. Many bodybuilders and athletes are concerned about the long-term health risks associated with DIM.
To increase testosterone production, most people take a diindolylmethane supplement. It is well-known that testosterone functions as an androgen. This means that it can cause hormonal changes within the tissues. Studies have proven DIM to mimic the effects both of testosterone and other hormones. Because men produce much more testosterone than women do, some manufacturers have added diindolylmethane to their products in order to increase their competitiveness in male circles. Men respond to products that are similar to testosterone that is naturally produced.
Many companies promote DIM as a tumor suppressor. It’s true that diindolylmethane does decrease the growth of tumors in laboratory animals, however these animals were given the drug, not orally. To achieve the same result in humans, diindolylmethane has to be consumed in high doses for a long period of time. The animals that were studied had no indications of cancer for a number of years. However, they all developed liver diseases after drinking excessive amounts of diindolylmethane. A doctor can give you a better understanding of the way DIM functions within the body.
According to the US National Institute of Environmental Health Safety and Security, the only way to demonstrate that DIM is effective in treating breast cancer is to perform an experiment wherein cells from healthy breast cancer cells are exposed to large doses of diindolylmethane over a prolonged period of time. As with any chemical, there are both pros and cons associated with using it. The ability to mimic hormones is one of the benefits. This means that you could make insulin, which could stop the proliferation of cancer cells. The cons include the fact diindolylmethane can also produce an extremely harmful chemical known as DMSO. Know more about what does diindolylmethane do now.
One of the most popular claims about diindolylmethane’s usage as treatment for various illnesses is that it functions as an natural, antibacterial, anticancer and anti-fungal agent. These claims were rejected by the National Institute of Health after an exhaustive review of supporting data. According to the Institute of Chemical Technology there was no evidence from any research that support this claim. In a thorough review of the safety characteristics of the firestone the Institute of Chemical Safety concluded that the evidence provided by pharmaceutical companies on the benefits to humans of diindolylmethane was not substantiated.
Van der Goes, et. al. published their findings in the May 2021 issue of the Journal of Toxicology and Environmental Health. Van der Goes, et al. identified the potential risks of diindolylmethane, which includes allergic reactions and skin rashes asthma attacks, as along with headaches, dizziness and respiratory issues. They also stated that the recommended daily allowance for this chemical is 0.2 milligrams or one 10th of a teaspoon. It is not known how much concentration it will have when this chemical is paired with other compounds. Because this substance has not been thoroughly examined, it isn’t considered safe at any point.
The abstract of the view shows the use of diindolylmethane in cancer treatment is based on the notion that intracellular inhibition of pyruvate metabolism by flavenoids can be slowed down and stops the accumulation of oxalates and pyruvate metabolites in renal tubule cells. The drug metabiplicate toxicology studies have not shown that this chemical can cause overdose. The Food and Drug Administration approved the substance as a prescription drug in June 1996. According to the FDA the manufacturer of firestone tincture is in the process of completing two major trials–one in Europe and one in the United States.
The view abstract also shows that diindolylmethane’s use in cancer treatment is based on the principle of inhibiting intracellular inhibition via flavenoids of pyruvate metabolism and thus stopping the accumulation of adenine and oxalates within the renal tubule cells. Metabiplicate toxicology studies on the drug have not shown that this chemical could cause overdose. The Food and Drug Administration approved this substance as a prescription drug in June 1996. According to the FDA the company that makes firestone Tincture is currently conducting two major trials in Europe and the United States. According to the FDA the company that produces firestone tincture is currently in the process of conducting two major trials in Europe and one in the United States.